医学
严格标准化平均差
置信区间
注意缺陷多动障碍
荟萃分析
安慰剂
梅德林
背景(考古学)
物理疗法
心理信息
随机对照试验
样本量测定
心理干预
儿科
精神科
内科学
替代医学
古生物学
病理
法学
统计
生物
数学
政治学
作者
Adam P. Goode,Remy R Coeytaux,Gary Maslow,Naomi Davis,Sherika Hill,Behrouz Namdari,Nancy M. Allen LaPointe,Deanna Befus,Kathryn R Lallinger,Samantha Bowen,Andrzej S. Kosinski,Amanda J McBroom,Gillian D Sanders,Alex R. Kemper
出处
期刊:Pediatrics
[American Academy of Pediatrics]
日期:2018-05-30
卷期号:141 (6)
被引量:54
标识
DOI:10.1542/peds.2018-0094
摘要
CONTEXT: Nonpharmacologic treatments for attention-deficit/hyperactivity disorder (ADHD) encompass a range of care approaches from structured behavioral interventions to complementary medicines. OBJECTIVES: To assess the comparative effectiveness of nonpharmacologic treatments for ADHD among individuals 17 years of age and younger. DATA SOURCES: PubMed, Embase, PsycINFO, and Cochrane Database of Systematic Reviews for relevant English-language studies published from January 1, 2009 through November 7, 2016. STUDY SELECTION: We included studies that compared any ADHD nonpharmacologic treatment strategy with placebo, pharmacologic, or another nonpharmacologic treatment. DATA EXTRACTION: Study design, patient characteristics, intervention approaches, follow-up times, and outcomes were abstracted. For comparisons with at least 3 similar studies, random-effects meta-analysis was used to generate pooled estimates. RESULTS: We identified 54 studies of nonpharmacologic treatments, including neurofeedback, cognitive training, cognitive behavioral therapy, child or parent training, dietary omega fatty acid supplementation, and herbal and/or dietary approaches. No new guidance was identified regarding the comparative effectiveness of nonpharmacologic treatments. Pooled results for omega fatty acids found no significant effects for parent rating of ADHD total symptoms (n = 411; standardized mean difference −0.32; 95% confidence interval −0.80 to 0.15; I2 = 52.4%; P = .10) or teacher-rated total ADHD symptoms (n = 287; standardized mean difference −0.08; 95% confidence interval −0.47 to 0.32; I2 = 0.0%; P = .56). LIMITATIONS: Studies often did not reflect the primary care setting and had short follow-up periods, small sample sizes, variations in outcomes, and inconsistent reporting of comparative statistical analyses. CONCLUSIONS: Despite wide use, there are significant gaps in knowledge regarding the effectiveness of ADHD nonpharmacologic treatments.
科研通智能强力驱动
Strongly Powered by AbleSci AI